REVERSE-TRANSCRIPTASE MUTATIONS IN SEQUENTIAL HIV-1 ISOLATES IN A PATIENT WITH AIDS

被引:17
作者
GURUSINGHE, AD
LAND, SA
BIRCH, C
MCGAVIN, C
HOOKER, DJ
TACHEDJIAN, G
DOHERTY, R
DEACON, NJ
机构
[1] MACFARLANE BURNET CTR MED RES,VIRUS INTERACT LAB,FAIRFIELD,VIC 3078,AUSTRALIA
[2] NATL CTR HIV VIROL RES,AIDS MOLEC BIOL LAB,FAIRFIELD,VIC,AUSTRALIA
[3] NATL CTR HIV VIROL RES,ANTIVIRALS RES LAB,FAIRFIELD,VIC,AUSTRALIA
[4] FAIRFIELD HOSP,VICTORIAN STATE HIV ISOLAT LAB,FAIRFIELD,VIC 3078,AUSTRALIA
关键词
HIV-1; AZT; RESISTANCE; REVERSE TRANSCRIPTASE; MUTATIONS;
D O I
10.1002/jmv.1890460312
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Sequential human immunodeficiency virus type 1 (HIV-1) isolates were obtained over a 29-month period from a person before, during, and after AZT therapy. DNA sequence analysis of polymerase chain-amplified reverse-transcriptase gene showed a gradual accumulation of mutations to peak resistance (IC50 2.13 mu M AZT) in association with mutations at codons 44, 210, and 369, as well as at 41, 67, 70, and 215. Eight months after cessation of AZT therapy, when an HIV-1 isolate from the patient was again sensitive to AZT, these mutations had all returned to the pretherapy sequence. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:238 / 243
页数:6
相关论文
共 22 条
[1]   IMPROVEMENT OF PCR AMPLIFIED DNA SEQUENCING WITH THE AID OF DETERGENTS [J].
BACHMANN, B ;
LUKE, W ;
HUNSMANN, G .
NUCLEIC ACIDS RESEARCH, 1990, 18 (05) :1309-1309
[2]   ALTERED SENSITIVITY TO ANTIVIRAL DRUGS OF HERPES-SIMPLEX VIRUS ISOLATES FROM A PATIENT WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BIRCH, CJ ;
TACHEDJIAN, G ;
DOHERTY, RR ;
HAYES, K ;
GUST, ID .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (03) :731-734
[3]   CLINICAL EFFECTS AND INVITRO STUDIES OF TRIFLUOROTHYMIDINE COMBINED WITH INTERFERON-ALPHA FOR TREATMENT OF DRUG-RESISTANT AND DRUG-SENSITIVE HERPES-SIMPLEX VIRUS-INFECTIONS [J].
BIRCH, CJ ;
TYSSEN, DP ;
TACHEDJIAN, G ;
DOHERTY, R ;
HAYES, K ;
MIJCH, A ;
LUCAS, CR .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) :108-112
[4]   ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS [J].
BOUCHER, CAB ;
OSULLIVAN, E ;
MULDER, JW ;
RAMAUTARSING, C ;
KELLAM, P ;
DARBY, G ;
LANGE, JMA ;
GOUDSMIT, J ;
LARDER, BA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :105-110
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL GENE-MUTATIONS IN AN AIDS PATIENT TREATED WITH MULTIPLE ANTIRETROVIRAL DRUGS [J].
FITZGIBBON, JE ;
FARNHAM, AE ;
SPERBER, SJ ;
KIM, H ;
DUBIN, DT .
JOURNAL OF VIROLOGY, 1993, 67 (12) :7271-7275
[6]   5TH MUTATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONTRIBUTES TO THE DEVELOPMENT OF HIGH-LEVEL RESISTANCE TO ZIDOVUDINE [J].
KELLAM, P ;
BOUCHER, CAB ;
LARDER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1934-1938
[7]   ZIDOVUDINE TREATMENT RESULTS IN THE SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WHOSE GENOTYPES CONFER INCREASING LEVELS OF DRUG-RESISTANCE [J].
KELLAM, P ;
BOUCHER, CAB ;
TIJNAGEL, JMGH ;
LARDER, BA .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :341-351
[8]  
KURITZKES DR, 1993, 1ST NAT C HUM RETR R, P55
[9]   REVERSION FROM ZIDOVUDINE RESISTANCE TO SENSITIVITY ON CESSATION OF TREATMENT [J].
LAND, S ;
MCGAVIN, K ;
BIRCH, C ;
LUCAS, R .
LANCET, 1991, 338 (8770) :830-831
[10]   DECREASED INVITRO SUSCEPTIBILITY TO ZIDOVUDINE OF HIV ISOLATES OBTAINED FROM PATIENTS WITH AIDS [J].
LAND, S ;
TRELOAR, G ;
MCPHEE, D ;
BIRCH, C ;
DOHERTY, R ;
COOPER, D ;
GUST, I .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (02) :326-329